Roger D. Tung
Chief Executive Officer, CONCERT PHARMACEUTICALS, INC.
Companies
- CONCERT PHARMACEUTICALS, INC.Board member Feb 12, 2014 to Mar 6, 20231
- CONCERT PHARMACEUTICALS, INC.Chief executive officer Feb 12, 2014 to Mar 6, 20231
- Decoy Therapeutics Inc.Board member Nov 6, 2017 to Jul 26, 20182
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CONCERT PHARMACEUTICALS, INC.0 shares3Mar 6, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 6, 2023U 12,389 shares of CONCERT PHARMACEUTICALS, INC.3
- Mar 6, 2023U 13,274 shares of CONCERT PHARMACEUTICALS, INC.3
- Mar 6, 2023U 121,873 shares of CONCERT PHARMACEUTICALS, INC.3
- Mar 6, 2023Returned to company 57,916 shares of CONCERT PHARMACEUTICALS, INC.3
- Mar 6, 2023U 756,427 shares of CONCERT PHARMACEUTICALS, INC.3
- Jan 6, 2023Sold 9,240 shares at $7.24 of CONCERT PHARMACEUTICALS, INC.4
- Feb 15, 2022Sold 13,480 shares at $3.09 of CONCERT PHARMACEUTICALS, INC.5
- Jan 28, 2022Granted 156,675 shares of CONCERT PHARMACEUTICALS, INC.6
- Jan 28, 2022Granted 52,225 shares of CONCERT PHARMACEUTICALS, INC.6
- Jan 6, 2022Sold 9,240 shares at $3.09 of CONCERT PHARMACEUTICALS, INC.7
- Dec 15, 2021Gift 7,500 shares of CONCERT PHARMACEUTICALS, INC.7
- Dec 14, 2021Gift 7,000 shares of CONCERT PHARMACEUTICALS, INC.7
- Dec 13, 2021Sold 6,700 shares at $3.62 of CONCERT PHARMACEUTICALS, INC.8
- Dec 13, 2021Exercised options 6,700 shares at $3.50 of CONCERT PHARMACEUTICALS, INC.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jan 9, 2023
- 5SEC EDGARForm 4 filed Feb 16, 2022
- 6SEC EDGARForm 4 filed Feb 1, 2022
- 7SEC EDGARForm 4 filed Jan 7, 2022
- 8SEC EDGARForm 4 filed Dec 15, 2021